“…Using methods agnostic to gene function, we have specifically implicated NOV / CCN3 , encoding a biologically-relevant protein: a) its overexpression is associated with abnormal maternal behaviour which can be reversed through antipsychotic administration (present study), b) it is located ∼138 cM on human chromosome 8, below the linkage peak indicated from a sample of individuals with bipolar affective puerperal psychosis (137.5–147.5 cM) (Jones et al, 2007), c) the associated protein is thought to modulate intracellular calcium signalling (Lombet et al, 2003) a process that goes awry in both bipolar disorder (Harrison, 2016) and PP (Riley and Watt, 1985), d) its expression is repressed by oestrogen (Vendrell et al, 2004), e) it encodes a regulator of placental angiogenesis and its expression is perturbed in cases of pre-eclampsia (Winterhager and Gellhaus, 2014), f) it is highly expressed in the cortex and limbic system of the adult human brain (Malik et al, 2015), g) it can regulate axonal outgrowth of callosal projection neurons (Park et al, 2015) consistent with corpus callosum abnormalities in PP cases (Udaya et al, 2015), h) it lies adjacent to a polymorphism associated with smoking cessation (Argos et al, 2014) and its expression is downregulated in female tissues exposed to cigarette smoke (Gueugnon et al, 2016), and i) small genomic duplications encompassing NOV / CCN3 have been associated with bipolar disorder (Macayran et al, 2006). Given possible thyroid dysfunction in PP (Bergink et al, 2011), it is also interesting that cortical Nov / Ccn3 and Adcy8 expression is regulated by 3,5,3′-triiodo- l -thyronine (T3) (Berbel et al, 2014).…”